Dongmai Roadshow Hall Launches with Five Innovative Healthcare Startups Showcased in Inaugural Online Pitch Event
Over the past five years,VCBeat, through 20 million words, 12,217 original articles, and 227 original reports, has witnessed the emergence and growth of nearly 5,000 innovative enterprises across 81 sub-sectors of medical innovation.Over the past five years, amid the relentless momentum of the healthcare industry, we have strived to cultivate fertile ground for high-potential innovative enterprises, witnessing and driving innovation and transformation within the healthcare sector.
As the connecting entity behind information, VCBeat will officially launch starting this week"VCBeat Roadshow Hall"Column: Curating top picks from a vast pool of projects every week5 Innovative Companies, conduct“Online Roadshow”。
Wenlan Medical : Chain Clinics for Burns and Scalds
Project Introduction:
Wenlan Medical is a vertically integrated, nationwide chain of burn care institutions specializing in R&D, production, and clinical treatment. Guided by the core principles of high-quality, low-cost, and accessible healthcare, the company manages a vertical full-industry-chain encompassing products, services, and marketing, while integrating and extending upstream and downstream industry resources. It is committed to establishing itself as China’s leading brand for comprehensive burn care solutions.
Wenlan Clinic, as the core operational entity of Wenlan Medical, carries the significant value of the Wenlan system and represents the core technology of Wenlan Medical.
a critical means of converting surgical patents into operational revenue, and also the core asset for Wenlan Medical in the capital markets in the future.
Team Member Information:
Wei Xiao: Founder
A distinguished representative of Shanxi merchants in Jiangsu, Vice President of the Suzhou Shanxi Chamber of Commerce, and Secretary-General of the Suzhou Branch of the Business Leaders Club, with extensive investment and management experience in private medical institutions and chain healthcare facilities.
Financing Information
Financing Needs:
Funding Round:Angel Round
Financing Amount:10 million
Diluted Equity Ratio:10%
Relevant Data:
Wenlan Medical: The Field of Burn and Scald Diagnosis and Treatment Should Not Be Limited to “Ancestral Secret Remedies”; Chain Clinics Will Open Up a New Blue Ocean
https://vcbeat.top/Article/searchArticle
Project Introduction:
Yaoshang.com is a developer and operator of 24-hour smart medication dispensing systems. By empowering retail pharmacies, it has built a “1+N” Smart Cloud Pharmacy service platform that integrates offline central pharmacies with N intelligent medication vending machines. The platform provides professional and convenient services, including 24/7 online medication guidance, 15-minute self-service purchase of urgent medications, and nearby pickup for chronic disease medications. As a participant in the formulation of industry standards for self-service medication vending machines, Yaoshang.com holds first-mover advantages in equipment and system R&D as well as in unmanned pharmaceutical retail operations, leading transformative developments in the industry.
Team Member Information:
Founder: Ju Jinyou,Former Sales Director for East China at Pfizer Pharmaceuticals (China), with over 15 years of experience in the pharmaceutical industry and extensive team management expertise.
Co-founder Lv Miao,Former Project Lead at Oracle Software (Suzhou) Co., Ltd.; Senior Software Engineer at Singtel Group (Suzhou). With over 10 years of experience in the IT industry, specializing in high-performance architecture design and complex system integration.
Financing Information
Financing Requirements:
Funding Round:Series A
Financing Amount:20 million
Funding History:
Financing Round 1: Angel Round
Financing Amount: Several Million RMB
Financing Round 2: Pre-A
Financing Amount: RMB 8 million (Changling Capital, etc.)
Relevant Data:
Yaoshang.com: B2B + B2C, Enabling Vending Machines to Bridge the Last Mile in Communities
Related Links:https://vcbeat.top/ODk4MGVlMGNiYjdlZjlmNDI5YTgwNjI4MmQ1MmYwYzc=
Project Introduction:
Walnut Health targets patients with cardiovascular and cerebrovascular diseases, proposing a "Home-Based Intelligent Rehabilitation" model. This initiative aims to leverage technologies such as the internet, big data, and artificial intelligence to connect doctors, devices, and patients, thereby providing integrated software-and-hardware home-based intelligent rehabilitation services. On one hand, Walnut Health offers systematic content and courses; on the other, the platform integrates professional home rehabilitation equipment to deliver at-home rehabilitation services to patients.
Team Member Information:
Wang Kai, CEO
Director of the Academic Department, Beijing Cerebrovascular Disease Industry Technology Innovation Strategic Alliance
12 years of experience in the pharmaceutical industry, with 5 years in the mobile health sector. An early employee of Chunyu Doctor, formerly served as Business Director, leading an 18-member team to achieve annual sales of nearly RMB 40 million.
Graduated from the University of International Relations in 2008.
Financing Information
Funding Requirements:
Funding Round: Pre-A
Financing Amount: 8 million
Financing History: Seed Round – Beijing Shangcheng Tongli Brand Management Co., Ltd. + VCBeat
Other Data:
Yujian Future Rehabilitation Platform Connects Doctors, Devices, and Patients: Where Does the Path to Cardiovascular and Cerebrovascular Rehabilitation Lie from a Systematic Content Perspective?
Related Links:https://vcbeat.top/YWJjZDdjOGViOWM0NGUyZmMxMGVlMTg4NTM0MGM4MWY=
Project Introduction:
Beijing IASONE Technology (IASONE), established in July 2015, is a medical technology company dedicated to the research and development of intelligent service robots. The company is currently developing an intelligent service robot oriented toward crisis identification and health management. Its core competitive advantage lies in its integrated technological combination of “autonomous navigation + 6-axis robotic arm + machine vision,” which enables adaptation to a wide range of application scenarios.
Team Member Information: For specific details on team members, please consult the relevant personnel at the enterprise.
Financing Information:
Funding Requirements:
Funding Round: Angel Round
Funding Amount: 7.5 million
Diluted Equity Stake: 15%
Relevant Data:
Machine Vision Identifies Crisis Events to Safeguard Elderly Health: Ruyi Tech Develops Companion Care Robots for the Aging Population
Related Links:https://vcbeat.top/MTQzOGViMGVhMjZhM2EzNTc3NTEzNjY4YzA5YmVmNTU=
Project Introduction:
Weikang Technology’s “Smart Prescription” adopts a “Server to Server” (serving the service providers) product design philosophy, emphasizing that the professional value of “human” expertise is indispensable to any mobile health service. Leveraging WeChat’s robust connectivity capabilities, it constructs a new ecosystem for community pharmaceutical care services. Built upon a big data interaction engine powered by WeChat’s multi-template messaging, and supported by underlying data systems such as a professional drug database, clinical indicators database, and clinical medication database, it establishes an intelligent platform for electronic prescription review, circulation, and dispensing. The platform provides community clinics and pharmacies with supply services for chronic disease prescription drugs and novel specialty drugs, online prescription review services by third-party pharmacists, as well as family doctor prescription circulation, prescribing, and storage services.
Team Member Information:
Chen Linjun, Co-Founder
Licensed Pharmacist, MBA from Sun Yat-sen University. With over 15 years of experience in internet-based pharmaceutical big data research, he has successfully incubated multiple internet projects in first-tier cities such as Beijing, Shanghai, Guangzhou, and Shenzhen. He participated in the founding of Daoyi.com and 5191 Health Network (21st Century Pharmacy Network), and established Q Yao Wang and Sudao Technology’s Yaoshibang APP. He is the founder of a Guangzhou-based internet pharmaceutical unicorn enterprise in 2018.
Xie Kai, Co-Founder
Senior Product Manager at Tencent, MBA from Jinan University, former core member of the Foxmail team, one of the earliest founding members of WeChat’s Guangzhou R&D Center, with 11 years of tenure at Tencent.
Founder and Leader of the QQ Mail product, with many years of experience in product planning, operations, and innovation for QQ Mail; early member of the WeChat Enterprise Account project, and Founder and Leader of its Business Operations Team.
Sheng Xinhai, Chief Operating Officer
M.S. in Science and Engineering, specializing in internet algorithm research. Extensive entrepreneurial experience in internet projects, overseeing product design and operations, and successfully driving projects from inception to launch. Primarily responsible for product design, operations, and user experience within the team.
Financing Information:
Financing Round: Pre-A
Financing Amount: 5 million
Equity Dilution Ratio: Approximately 15%
Funding History:
Funding Round: Angel Round (2017) Guangzhou Yihang Investment Center
Relevant Data:
Focusing on Third-Party Community Pharmaceutical Services: How Does Weikang Technology Empower Grassroots Communities by Establishing Health Management Records for Chronic Disease Patients Starting with Prescriptions? [Grassroots Healthcare Case Study]
Related Links:https://vcbeat.top/NzE1MDQ1NmUwYWU1NzljMTY3MDcyYzAyNzRkNzFhNzQ=
Above is the company information for the first session of the “Artery Roadshow Hall.” For business plans and other related information, please contact Xiao Yun at VCBeat (WeChat ID: DongMai_Investent). If you are also an innovator in the healthcare industry seeking opportunities, you are welcome to reach out.